UNSPSC 85811213: Introduction of monoclonal antibody into peritoneal cavity, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into peritoneal cavity, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0M30M

UNSPSC 85811213, Introduction of monoclonal antibody into peritoneal cavity, percutaneous approach, is a Commodity code that appears to have minimal alignment with actual state and local procurement activity. The recent opportunities block contains no solicitations matching this medical procedure code; instead, the tagged opportunities span telehealth urgent care, general medical services, PACE operations, occupational health, cancer screening, behavioral health, EMS billing, and other clinical service categories that do not correspond to the specific interventional immunotherapy procedure named in the code.

State and local health plans, counties, and health authorities are actively buying clinical services, preventive care, treatment programs, and health administration work—but the recent activity shows no demand for monoclonal antibody peritoneal infusion procedures as a discrete procurement line. The code's narrow procedural scope and the absence of matching solicitations suggest either that this particular therapeutic intervention is not widely procured by state and local bodies as a standalone contract service, or that when it is needed, it is bundled within broader healthcare delivery or specialty treatment agreements that are tagged to higher-level Family or Class codes. Agencies pursuing this Commodity code should verify current demand signals within their target jurisdictions before building business development resources around it.